MedPath

Comparison of two drugs for premedication in children planned for MRI

Phase 4
Conditions
Health Condition 1: G00-G99- Diseases of the nervous system
Registration Number
CTRI/2024/05/066613
Lead Sponsor
Department of Anesthesia and Pain Medicine Pt JNM Medical College Raipur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA GRADE I AND II

BODY WT 10-20 KG

SCHEDULED FOR MRI UNDER SEDATIO

Exclusion Criteria

1.Not nil by mouth

2.Parents refusal

3.Duration of scan more than 60-90 mins

4 Congenital heart disease, upper respiratory tract infection,

5.Pts. on Antipsychotics, Anticonvulsants, any sedative drugs.

6. Pts with altered sensorium

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
evel of sedation as assessed by OAA/S scale <br/ ><br>(Observer Assessment of Alertness/Sedation Score)Timepoint: The time of dosage will be noted, and the observer will record SpO2, HR and the sedation level at 5-min intervals for 30min following drug administration. <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1.Onset of sedation <br/ ><br>2. Ease of Parental Separation <br/ ><br>3.Changes in Hemodynamic parameters <br/ ><br>4.Total dose of requirement of supplemental Fentanyl. <br/ ><br>Timepoint: The time of dosage will be noted, and the observer will record SpO2, HR at 5-min intervals for 30min following drug administration. <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath